Telix Pharmaceuticals Company Top Insiders

TLPPF Stock  USD 16.00  0.82  5.40%   
Telix Pharmaceuticals employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Telix Pharmaceuticals' management performance can provide insight into the company performance.
Jyoti BappSc  Insider
Chief APAC
Meredith Crowe  Insider
Interim Culture
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Telix Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.4111) % which means that it has lost $0.4111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5507) %, meaning that it generated substantial loss on money invested by shareholders. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Telix Pharmaceuticals Workforce Comparison

Telix Pharmaceuticals Limited is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 25,621. Telix Pharmaceuticals adds roughly 11.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Telix Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Telix Pharmaceuticals Price Series Summation is a cross summation of Telix Pharmaceuticals price series and its benchmark/peer.

Telix Pharmaceuticals Notable Stakeholders

A Telix Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Telix Pharmaceuticals often face trade-offs trying to please all of them. Telix Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Telix Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jyoti BappScChief APACProfile
Meredith CroweInterim CultureProfile
BSc BScChief ScientistProfile
Christian DavisEMEA MarketingProfile
Andreas MDChief DirectorProfile
Amanda GriffinCommunications MangProfile
BEng DPhilGroup CoFounderProfile
Kyahn WilliamsonSr RelationsProfile
BBus FCPAGroup OfficerProfile
Lena MoranAdamsG CounselProfile
AGIA ACGRisk GovernanceProfile

About Telix Pharmaceuticals Management Performance

The success or failure of an entity such as Telix Pharmaceuticals often depends on how effective the management is. Telix Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Telix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Telix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Telix Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Telix Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Telix Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Telix Pharmaceuticals within its industry.

Telix Pharmaceuticals Manpower Efficiency

Return on Telix Pharmaceuticals Manpower

Revenue Per Employee445.3K
Revenue Per Executive445.3K
Net Loss Per Employee7.3M
Net Loss Per Executive7.3M

Complementary Tools for Telix Pink Sheet analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments